FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma
Acta Biochimica et Biophysica Sinica · 2024
DOI: 10.3724/abbs.2024082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2024. Verfasst von Liangliang Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospit…. Hauptthemen laut MEDLINE: Kinesins, Drug Resistance, Neoplasm, Adenocarcinoma of Lung, Docetaxel. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China.
- Department of Education Office, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China.
- Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China.
Zitieren
APA
Dong, L., Feng, C., Cheng, W., Huang, A., & Ying, K. (2024). FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024082
Vancouver
Dong L, Feng C, Cheng W, Huang A, Ying K. FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024082
BibTeX
@article{Dong2024,
author = {Dong, Liangliang and Feng, Chan and Cheng, Wenwen and Huang, Aihua and Ying, Kejing},
title = {FOXP3 targets KIF5A to increase lactate production and promote docetaxel resistance in lung adenocarcinoma},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2024},
doi = {10.3724/abbs.2024082}
}
EUVIMED